TOR signaling and rapamycin influence longevity by regulating SKN-1/Nrf and DAF-16/FoxO.

Cell Metabolism
Stacey Robida-StubbsT Keith Blackwell

Abstract

The TOR kinase, which is present in the functionally distinct complexes TORC1 and TORC2, is essential for growth but associated with disease and aging. Elucidation of how TOR influences life span will identify mechanisms of fundamental importance in aging and TOR functions. Here we show that when TORC1 is inhibited genetically in C. elegans, SKN-1/Nrf, and DAF-16/FoxO activate protective genes, and increase stress resistance and longevity. SKN-1 also upregulates TORC1 pathway gene expression in a feedback loop. Rapamycin triggers a similar protective response in C. elegans and mice, but increases worm life span dependent upon SKN-1 and not DAF-16, apparently by interfering with TORC2 along with TORC1. TORC1, TORC2, and insulin/IGF-1-like signaling regulate SKN-1 activity through different mechanisms. We conclude that modulation of SKN-1/Nrf and DAF-16/FoxO may be generally important in the effects of TOR signaling in vivo and that these transcription factors mediate an opposing relationship between growth signals and longevity.

References

Apr 12, 2003·Science·Siu Sylvia LeeGary Ruvkun
Jul 19, 2003·Genes & Development·Jae Hyung An, T Keith Blackwell
Dec 12, 2003·Nature·Tibor VellaiFritz Müller
May 14, 2004·Proceedings of the National Academy of Sciences of the United States of America·Cheng HuangKerry Kornfeld
Aug 7, 2004·Developmental Cell·Ryan C ScottThomas P Neufeld
May 20, 2005·Current Opinion in Cell Biology·David L Bentley
Feb 14, 2006·Cell·Stephan WullschlegerMichael N Hall
May 25, 2006·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Samuel T HendersonThomas E Johnson
Feb 3, 2007·Aging Cell·Kally Z PanPankaj Kapahi
Jul 7, 2007·Genome Biology·Joshua J McElweeDavid Gems
Aug 8, 2007·Gene·Hiroshi QadotaKozo Kaibuchi
Dec 25, 2007·Nature Structural & Molecular Biology·Kira Glover-CutterDavid L Bentley
Sep 23, 2008·Current Biology : CB·Karyn L SheafferSusan E Mango
Oct 2, 2008·The Journal of Biological Chemistry·Makiko OhtsujiMasayuki Yamamoto
Feb 26, 2009·Genes & Development·Alexander A SoukasGary Ruvkun
Apr 3, 2009·Nature Reviews. Molecular Cell Biology·Xiaoju Max Ma, John Blenis
Jun 23, 2009·Biochimica Et Biophysica Acta·Monique N StanfelBrian K Kennedy
Oct 3, 2009·Science·Colin SelmanDominic J Withers
Oct 8, 2009·Cell Metabolism·Kim LohTony Tiganis
Sep 30, 2010·EMBO Molecular Medicine·Andrei V BudanovMichael Karin
Dec 16, 2010·Nature Reviews. Molecular Cell Biology·Roberto ZoncuDavid M Sabatini
Mar 8, 2011·Cell·Vittoria ZinzallaMichael N Hall
Mar 29, 2011·Biochimica Et Biophysica Acta·Nissim Hay
Jul 22, 2011·Toxicological Sciences : an Official Journal of the Society of Toxicology·Kai Connie WuCurtis D Klaassen

❮ Previous
Next ❯

Citations

Jun 7, 2013·Biogerontology·Yuehua WeiYing Cai
Apr 9, 2013·Trends in Molecular Medicine·Annemieke T van der Goot, Ellen A A Nollen
Oct 8, 2013·Cell Death and Differentiation·D Lettieri BarbatoM R Ciriolo
Jan 18, 2013·Nature·Simon C JohnsonMatt Kaeberlein
May 24, 2013·Nature·Riekelt H HoutkooperJohan Auwerx
Aug 3, 2012·Nature Cell Biology·Marco Sandri
May 15, 2013·Nature Reviews. Drug Discovery·Pénélope A AndreuxJohan Auwerx
Mar 5, 2013·The Journal of Clinical Investigation·Dudley W LammingJoseph A Baur
Dec 6, 2012·Biology Open·Masamitsu FukuyamaToshiaki Katada
Mar 21, 2013·F1000prime Reports·Matt Kaeberlein
Apr 3, 2014·PLoS Biology·Athanasios MetaxakisLinda Partridge
Sep 27, 2013·PLoS Genetics·Kira M Glover-CutterT Keith Blackwell
Sep 27, 2013·PLoS Genetics·Keith P Choe, Chi K Leung
Apr 26, 2014·PLoS Genetics·Elite PossikArnim Pause
May 6, 2014·Biochemistry. Biokhimii︠a︡·A A ParkhitkoE P Henske
Jan 1, 2014·Scientifica·Matt Kaeberlein
Jul 16, 2013·Molecular Neurobiology·Chong WangLan Tan
Oct 8, 2013·Antioxidants & Redox Signaling·Bedoor QabazardPhilip K Moore
Feb 22, 2014·Age·Alessandro BittoChristian Sell
Nov 30, 2012·Annual Review of Physiology·David Gems, Linda Partridge
Oct 12, 2014·Age·Ravi Raghav SonaniDatta Madamwar
Dec 6, 2014·Cell Death & Disease·M V Blagosklonny
Jan 24, 2014·Antioxidants & Redox Signaling·Emilio SiendonesPlácido Navas
Feb 20, 2014·European Journal of Nutrition·Yukie YaguchiYoshikazu Nishikawa
Sep 24, 2013·Natural Product Reports·Aikaterini ArgyropoulouAlexios-Leandros Skaltsounis
Apr 24, 2014·Journal of Clinical Medicine·Lisa B Boyette, Rocky S Tuan
Oct 5, 2015·Journal of Industrial Microbiology & Biotechnology·Louis K Ho, Justin R Nodwell
Jan 19, 2016·Biochimica Et Biophysica Acta·Lifen Xu, Marijke Brink
Jan 15, 2016·Mechanisms of Ageing and Development·Cihan Suleyman ErdoganOle Vang
Aug 2, 2015·Free Radical Biology & Medicine·T Keith BlackwellMeltem Isik
Dec 24, 2015·Aging Cell·Emma L BaarDudley W Lamming
Sep 4, 2012·Trends in Endocrinology and Metabolism : TEM·Louis R Lapierre, Malene Hansen
Dec 17, 2015·Molecular Biology of the Cell·Race DiLoreto, Coleen T Murphy
May 15, 2015·Redox Biology·Aimilia D SklirouIoannis P Trougakos
Oct 8, 2015·Rejuvenation Research·Mahtab Jafari
Dec 18, 2015·Aging Cell·Shaun CalvertJoão Pedro de Magalhães

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anthelmintics (ASM)

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Cardiomegaly

Cardiomegaly, known as an enlarged heart, is a multifactorial disease with different pathophysiological mechanisms. Hypertension, pregnancy, exercise-induced and idiopathic causes are some mechanisms of cardiomegaly. Discover the latest research of cardiomegaly here.

Autophagy & Metabolism

Autophagy preserves the health of cells and tissues by replacing outdated and damaged cellular components with fresh ones. In starvation, it provides an internal source of nutrients for energy generation and, thus, survival. A powerful promoter of metabolic homeostasis at both the cellular and whole-animal level, autophagy prevents degenerative diseases. It does have a downside, however--cancer cells exploit it to survive in nutrient-poor tumors.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Parkinson's Disease & Autophagy (MDS)

Autophagy leads to degradation of damaged proteins and organelles by the lysosome. Impaired autophagy has been implicated in several diseases. Here is the role of autophagy in Parkinson’s disease.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Autophagy & Disease

Autophagy is an important cellular process for normal physiology and both elevated and decreased levels of autophagy are associated with disease. Here is the latest research.